Planet Green Holdings Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Planet Green Holdings Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.04M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $17.66M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $44.76M | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $37.77M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.64M | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | $1.11M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $6.83M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $5.11M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $79.67M | Apr 17, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.9K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $554.6K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.58M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $4.35M | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $3.85M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.27M | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | $642.1K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $304.7K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($355.0K) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $10.50M | Apr 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($26.98M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($7.33M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($20.84M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($25.81M) | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | ($9.99M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($11.05M) | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | $2.95M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $16.83M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($78.31M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($136.36M) | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.64M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.58M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($6.56M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($5.27M) | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | ($6.24M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.79M) | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | ($302.9K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($584.4K) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($41.35M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($36.42M) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.2K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $57.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $54.9K | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $402.7K | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $808.4K | Mar 31, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.79M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $811.8K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($5.28M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($9.01M) | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | ($519.4K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.50M) | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | ($5.42M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($14.15M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($360.1K) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($29.79M) | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.8K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.2K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $26.4K | Apr 11, 2025 |
| FY2022 | Dec 31, 2021 | $1.39M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $695.5K | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | $578.6K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $490.7K | May 14, 2020 |
| FY2017 | Dec 31, 2017 | $314.2K | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $0 | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $1.92M | Oct 31, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.21M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $25.42M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $42.63M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $60.72M | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $86.02M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $21.97M | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | $25.90M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $17.21M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $68.49M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $148.25M | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.38M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $13.72M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $23.19M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $20.13M | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $34.76M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.66M | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | $5.16M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $9.92M | May 14, 2020 |
| FY2017 | Dec 31, 2017 | $79.28M | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $82.16M | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $11.69M | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | $19.44M | Apr 11, 2025 |
| FY2024 | Dec 31, 2022 | $40.59M | Apr 11, 2025 |
| FY2020 | Dec 31, 2020 | $18.31M | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $20.73M | Mar 31, 2021 |
| FY2017 | Dec 31, 2017 | ($3.05M) | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $58.77M | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $200.54M | Oct 31, 2017 |
| FY2016 | Dec 31, 2014 | $209.77M | Oct 31, 2017 |
| FY2015 | Dec 31, 2013 | $2.45M | Apr 14, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.0K | Mar 31, 2026 |
| FY2025 | Nov 26, 2025 | $7.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.72M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.72M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $4.72M | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $18.18M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.34M | Mar 9, 2023 |
| FY2015 | Dec 31, 2015 | $3.22M | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | $10.33M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $0 | Apr 15, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($175.03M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($148.05M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($140.72M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($119.88M) | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | ($94.07M) | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($84.33M) | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | ($73.28M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($79.04M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($99.63M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($36.40M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $750.7K | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $3.42M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $7.27M | Feb 6, 2023 |
| FY2020 | Dec 31, 2018 | $16.9K | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $89.2K | May 14, 2020 |
| FY2018 | Dec 31, 2016 | $426.1K | Apr 16, 2019 |
| FY2017 | Dec 31, 2015 | $17.14M | Apr 17, 2018 |
| FY2016 | Dec 31, 2014 | $23.69M | Oct 31, 2017 |
| FY2015 | Dec 31, 2013 | $33.86M | Apr 14, 2016 |
| FY2014 | Dec 31, 2012 | $32.35M | Apr 15, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $411.0K | Apr 11, 2025 |
| FY2023 | Dec 31, 2023 | $3.81M | Dec 13, 2024 |
| FY2023 | Dec 31, 2022 | $287.2K | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | $380.3K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $31.4K | Mar 9, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Dec 13, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Dec 13, 2024 |
| FY2021 | Dec 31, 2021 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Mar 9, 2023 |
| FY2015 | Dec 31, 2015 | 0 | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Mar 30, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Dec 13, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Dec 13, 2024 |
| FY2021 | Dec 31, 2021 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 6 | May 14, 2020 |
| FY2017 | Dec 31, 2017 | (5) | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | (3) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Oct 31, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Apr 14, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.23M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 7.28M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 7.28M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 72.08M | Dec 13, 2024 |
| FY2022 | Dec 31, 2021 | 35.58M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 11.81M | Mar 9, 2023 |
| FY2020 | Dec 31, 2019 | 7.88M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 5.50M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 1.53M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 38.27M | Apr 17, 2018 |